458
Participants
Start Date
November 11, 2024
Primary Completion Date
October 31, 2025
Study Completion Date
September 30, 2027
Amulet™ 2 Left Atrial Appendage (LAA) Occluder
Patient will undergo the implantation of the Amulet™ 2 Left Atrial Appendage (LAA) Occluder
NYU Langone Health, New York
Mount Sinai Hospital, New York
Roper Hospital, Charleston
Trident Medical Center, Charleston
Northside Hospital, Atlanta
Baptist Medical Center, Jacksonville
AdventHealth Orlando, Orlando
Vanderbilt Heart & Vascular Institute, Nashville
Henry Ford Providence Southfield Hospital, Southfield
Mayo Clinic, Rochester
Kansas City Cardiac Arrhythmia Research Foundation, Overland Park
CHI Health Creighton University Medical Center-Bergan Mercy, Omaha
Arrhythmia Research Group, Jonesboro
Baylor Scott & White - The Heart Hospital Plano, Plano
Baylor Scott & White All Saints Medical Center, Fort Worth
Vital Heart and Vein, Humble
Heart Rhythm Associates, Shenandoah
Texas Cardiac Arrhythmia, Austin
Arizona Arrhythmia Research Group, Phoenix
Hôpital Civil Marie Curie, Lodelinsart
Vancouver General Hospital (U of BC), Vancouver
Institut de Cardiologie de Montreal (Montreal Heart Inst.), Montreal
Aarhus Universitetshospital, Aarhus
Rigshospitalet, Copenhagen
CHU Gabriel Montpied, Clermont-Ferrand
Institute Cardio. Paris-Sud - Institut Jacques Cartier, Massy
Cardioangiologisches Centrum am Bethanien Krankenhaus, Frankfurt am Main
Deutsches Herzzentrum der Charité, Berlin
Universitätsklinikum Schleswig-Holstein - Campus Lübeck, Lübeck
Heinrich-Braun-Klinikum gemeinnützige gGmbH Standort Zwickau, Zwickau
Ospedale San Raffaele, Milan
Hospital Clínic de Barcelona, Barcelona
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat
Hospital Clinico San Carlos, Madrid
Hospital Universitario de Salamanca, Salamanca
Center Inselspital Bern, Bern
University of Ottawa Heart Institute, Ottawa
Lead Sponsor
Abbott Medical Devices
INDUSTRY